The most widely used drug globally continues to be cannabis. Estimated 188 million people having used the drug in 2017.
North America – 23 countries, population of 579 million. Estimated $13 Billion  & $36 Billion  *editors note: US accounted for ~ 96% of total market share
Africa – Home to five of the world’s top 30 highest consumption rates around the world: #3 Nigeria, #10 Zambia, #14 Madagascar, #25 Egypt, #30 Sierra Leone). Estimated $7.1 Billion . More information displayed below.
Europe – 40+ countries, population of 742 million. Estimated market value of $60 Billion 
Latin America – 42 countries, population of 650 million. Estimated market value of $125 million  & $12 Billion  *editor’s note: projected 10x increase in a 10 year span
Oceanic – 30+ countries, population of 40 million. Estimated market value of $5.6 Billion  & $8.7 Billion 
Healthcare Coverage: Germany, Israel, Italy, and Denmark all offer full medical aid coverage for patient’s cannabis-based medicines. The US & Canada do not cover the costs.
Major Players in global cannabis: Aurora Cannabis, Canopy Growth Corporation (formerly Tweed Marijuana Inc.), Wayland Group (formerly Maricann Group Inc.), GW Pharmaceuticals, Aphria Inc., Tilray, The Cronos Group, ABcann Medicinals Inc., Lexaria Corp., and Organigram Holding Inc.
Contact: David Katz – firstname.lastname@example.org